Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski's description of PSP 40 years ago and Albert's delineation of the subcortical dementia 30 years ago

Neurocase

Volumn 11, Issue 4, 2005, Pages 250-262

  Magherini, A ^a,b   Litvan, Irene ^a,c  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; DONEPEZIL; NEUROTRANSMITTER;

ALZHEIMER DISEASE; APHASIA; APRAXIA; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHOLINERGIC SYSTEM; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; DYSPHAGIA; GAIT DISORDER; HUMAN; LEARNING DISORDER; MEMORY DISORDER; MOTOR DYSFUNCTION; NEUROPATHOLOGY; PARKINSON DISEASE; PERCEPTION DISORDER; PERSONALITY DISORDER; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW;

BEHAVIOR; COGNITION; COGNITION DISORDERS; HISTORY, 20TH CENTURY; HUMANS; NEUROPSYCHOLOGICAL TESTS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 23844517178     PISSN: 13554794     EISSN: None     Source Type: Journal    
DOI: 10.1080/13554790590962979     Document Type: Review

References (94)

1. Aarsland D, Litvan I, Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001; 13(1): 42-9.
2. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: Comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003; 74(9): 1215-20.
3. Alajouanine T, Delafontaine P, Lacan J. Fixite' du regard par hypertonie, predominant dans le sens vertical, avec conservation des mouvements automatico-reflexes, aspect special de syndrome de Parinaud par hypertonie assciee a un syndrome extrapyramidal avec troubles pseudo-bulbaires. Revue Neurologique 1926; 33: 410-418.
4. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37(2): 121-30.
5. Boeve B, Dickson D, Duffy J, Bartleson J, Trenerry M, Petersen R. Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol 2003; 49(2): 72-8.
6. Bogaert L van Bertrand I. Une variete' d'atrophie olivo-pontine a evolution subaigue avec troubles dementiels. Revue Neurologique 1929; 1 Semestre: 165-178.
7. Boller F, Mizutani T, Roessmann U, Gambetti P. Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol 1980; 7(4): 329-35.
8. Bonfiglioli C, De Berti G, Nichelli P, Nicoletti R, Castiello U. Kinematic analysis of the reach to grasp movement in Parkinson's Disease and Huntington's Disease subjects. Neuropsychologia 1998; 36: 1203-1208.
9. Brunel H, Michel BF, Pasquier J, Gastaut JL. Value of single photon emission computed tomography in the characterization of fronto-temporal dementia subtypes. J Neuroradiol 2003; 30(1): 37-45.
10. Cambier J, Masson M, Viader F, Limodin J, Strube A. Frontal syndrome of progressive supranuclear palsy Rev Neurol (Paris). 1985; 141(8-9): 528-36.
11. Castiello U, Bennett K, Bonfiglioli C, Lim S, Peppard RF. The reach-to-grasp movement in Parkinson's disease: Response to a simultaneous perturbation of object position and object size. Exp Brain Res 1999; 125: 453-462.
12. Costello AL, Warrington EK. Dynamic aphasia: The selective impairment of verbal planning. Cortex 1989; 25(1): 103-14.
13. Cummings JL, Benson DF. Subcortical dementia. Review of an emerging concept. Arch Neurol 1984; 41(8): 874-9.
14. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44(12): 2308-14.
15. D'Antona R, Baron J, Samson Y. Subcortical Dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain 1985; 108(Pt3): 785-799.
16. Dubois B, Deweer B, Pillon B. The cognitive syndrome of progressive supranuclear palsy. Adv Neurol 1996; 69: 399-403.
17. Dubois B, Pillon B, Legault F, Agid Y, Lhermitte F. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Arch Neurol 1988; 45(11): 1194-9.
18. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A Frontal Assessment Battery at bedside. Neurology 2000; 55(11): 1621-6.
19. Ebersbach G, Trottenberg T, Hattig H, Schelosky L, Schrag A, Poewe W. Directional bias of initial visual exploration. A symptom of neglect in Parkinson's disease. Brain 1996; 119(Pt1): 79-87.
20. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003; 2(4): 229-37.
21. Esmonde T, Giles E, Gibson M, Hodges JR. Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. J Neurol 1996; 243(9): 638-43.
22. Esmonde T, Giles E, Xuereb J, Hodges J. Progressive supranuclear palsy presenting with dynamic aphasia. J Neurol Neurosurg Psychiatry 1996; 60(4): 403-10.
23. Faglioni P, Saetti MC, Botti C. Verbal learning strategies in Parkinson's disease. Neuropsychology 2000; 14(3): 456-70.
24. Fellows SJ, Noth J, Schwarz M. Precision grip and Parkinson's disease. Brain 1998; 121: 1771-1784.
25. Fisk JD, Goodale MA, Burkhart G, Barnett HJ. Progressive supranuclear palsy: The relationship between ocular motor dysfunction and psychological test performance. Neurology 1982; 32: 698-705.
26. Frattali CM, Duffy JR, Litvan I, Patsalides AD, Grafman J Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control?. Eur J Neurol 2003; 10(1): 103-6.
27. Frattali CM, Grafman J, Patronas N, Makhlouf F, Litvan I. Language disturbances in corticobasal degeneration. Neurology 2000; 54(4): 990-2.
28. Ghika J, Tennis M, Growdon J, Hoffman E, Johnson K. Environment-driven responses in progressive supranuclear palsy. J Neurol Sci 1995; 130(1): 104-11.
29. Gnanalingham KK, Byrne BJ, Thornton A. Clock-face drawing to differentiate Lewy Body and Alzheimer type dementia syndromes. Lancet 1996; 347: 696-697.
30. Grafman J, Litvan I, Gomez C, Chase TN. Frontal lobe function in progressive supranuclear palsy. Arch Neurol 1990; 47(5): 553-8.
31. Graham NL, Bak TH, Hodges JR. Corticobasal degeneration as a cognitive disorder. Mov Disord 2003; 18(11): 1224-32.
32. Grossman M, McMillan C, Moore P, Ding L, Glosser G, Work M, Gee J. What's in a name: Voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain 2004; 127(Pt3): 628-49.
33. Hakim AM, Mathieson G. Dementia in Parkinson disease: A neuropathologic study. Neurology 1979; 29(9 Pt 1): 1209-14.
34. Heilman KM, Rothi LJC Apraxia. In: KM, Heilman, E, Valenstein, editors. Clinical neuropsychology, 2nd ed. New York: Oxford University Press, 1985; 141-150.
35. Helm-Estabrooks N. Test of oral and limb apraxia. Chicago, II: Riverside Publishing Company, 1992.
36. Henik A, Rafal R, Rhodes D. Endogenously generated and visually guided saccades after lesions of the human frontal eye fields. Soc. Neurosc Abstr 1991; 17: 809.
37. Jasper HH, Proctor LD, Knighton RS, Noshay WC, Costello RT. Reticular formation of the brain. Boston: Little, Brown, 1958.
38. Johnson R Jr. Event-related brain potentials. In: I, Litvan, Y, Agid, editors. Progressive supranuclear palsy: Clinical and research approaches. Oxford University Press: New York, 1992; 122-154.
39. Johnson R Jr, Litvan I, Grafman J. Progressive supranuclear palsy: Altered sensory processing leads to degraded cognition. Neurology 1991; 41(8): 1257-62.
40. Josephs KA, Dickson DW. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 2003; 18(9): 1018-26.
41. Kertesz A. Pick Complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. Neurolog 2003; 9(6): 311-7.
42. Kimura J, Barnett HJ, Burkhart G. The psychological test pattern in progressive supranuclear palsy. Neuropsychologia 1981; 19: 301-306.
43. Klainer-Fisman G, Black SE, Lang AE. Neurodegenerative disease and the evolution of art: The effects of presumed corticobasal degeneration in a professional artist. Mov Disord 2003; 18: 294-302.
44. Kluin KJ, Foster NL, Berent S, Gilman S Perceptual analysis of speech disorders in progressive supranuclear palsy. Neurology 1993; 43(3 Pt 1): 563-6.
45. Kulisevsky J, Litvan I, Berthier ML, Pascual-Sedano B, Paulsen JS, Cummings JL. Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders. Mov Disord 2001; 16(6): 1099-104.
46. Lange KW, Tucha O, Alders GL, Preier M, Csoti I, Merz B, Mark G, Herting B, Fornadi F, Reichmann H, Vieregge P, Reiners K, Becker G, Naumann M. Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm 2003; 110(9): 983-95.
47. Laplane D, Levasseur M, Pillon B, Dubois B, Baulac M, Mazoyer B, Tran Dinh S, Sette G, Danze F, Baron JC. Obsessive-compulsive and other behavioral changes with bilateral basal ganglia lesions. A neuropsychological magnetic resonance imaging and positron tomography study. Brain 1989; 112(Pt3): 699-725.
48. Lee AC, Harris JP, Atkinson E, Fowler MS. Evidence from a line bisection task for visuospatial neglect in left hemiparkinson's disease. Vision Res 2001; 41: 2677-2686.
49. Lee AC, Harris JP, Calvert JE. Impairments of mental rotation in Parkinson's disease. Neuropsychologia 1998; 36: 109-114.
50. Lees AJ. The concept of bradyphrenia. Rev Neurol (Paris) 1994; 150(12): 823-6.
51. Leiguarda R. Limb apraxia: Cortical or subcortical. [Rewiev] Neuroimage. 2001; 14(1 Pt2): S137-41.
52. Leiguarda R, Pramstaller P, Merello M, Strakstein S, Lees A, Marsden CD. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain 1997; 120: 75-90.
53. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I. Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998; 10(3): 314-9.
54. Litvan I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl 1994; 42: 69-78.
55. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996; 47(1): 1-9.
56. Litvan I, Cummings JL, Mega M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 1998; 65(5): 717-21.
57. Litvan I, Grafman J, Gomez C, Chase TN. Memory impairment in patients with progressive supranuclear palsy. Arch Neurol 1989; 46(7): 765-7.
58. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996; 47(5): 1184-9.
59. Litvan I, Paulsen JS, Mega MS, Cummings JL. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol 1998; 55(10): 1313-9. Erratum in: Arch Neurol 1998; 55(12): 1591.
60. Litvan I, Phipps M, Pharr VL, Hallett M, Grafman J, Salazar A. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology 2001; 57(3): 467-73.
61. McHugh PR, Folstein MF Psychiatric syndromes of Huntington's Chorea: A clinical and phenomenologic study. In: DF, Benson, D, Blumer, editors. Psychiatric aspects of neurologic disease. New York: Grune & Stratton Inc, 1975; 267-285.
62. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47(5): 1113-24.
63. Mentis MJ, Dhawan V, Feigin A, Delalot D, Zgaljardic D, Edwards C, Eidelberg D. Early stage Parkinson's disease patients and normal volunteers: Comparative mechanisms of sequence learning. Hum Brain Mapp 2003; 20(4): 246-58.
64. Mochizuki A, Ueda Y, Komatsuzaki Y, Tsuchiya K, Arai T, Shoji S. Progressive supranuclear palsy presenting with primary progressive aphasia. Clinicopathological report of an autopsy case. Acta Neuropathol (Berl) 2003; 105(6): 610-4.
65. Montse A, Pere V, Carme J, Francesc V, Eduardo T. Visuospatial deficits in Parkinson's Disease assessed by judgment of line orientation test: Error analyses and practice effects.. J Clin Exp Neuropsychol 2001; 23: 592-598.
66. Pharr V, Uttl B, Stark M, Litvan I, Fantie B, Grafman J. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 2001; 56(7): 957-63.
67. Pillon B, Blin J, Vidailhet M, Deweer B, Sirigu A, Dubois B, Agid Y The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995; 45(8): 1477-83.
68. Pillon B, Deweer B, Agid Y, Dubois B. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol 1993; 50(4): 374-9.
69. Pillon B, Deweer B, Michon A, Malapani C, Agid Y, Dubois B Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases. Neurology 1994; 44(7): 1264-70.
70. Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 1986; 36(9): 1179-85.
71. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991; 41(5): 634-43.
72. Pillon B, Gouider-Khouja N, Deweer B, Vidailhet M, Malapani C, Dubois B, Agid Y. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995; 58(2): 174-9.
73. Pollock M, Hornabrook RW. The prevalence, natural history and dementia of Parkinson's disease. Brain 1966; 89: 429-448.
74. Posner MI, Rafal RD, Choate L, Vaughn J. Inhibition of return: Neural basis and function. Cogn Neuropsychol 1985; 2: 211-228.
75. Posner MI, Walker JA, Friedrich FJ, Rafal RD. Effects of parietal injury on covert orienting of attention. J Neurosci 1984; 4: 1869-1874.
76. Purpura DP, Yahr MD The thalamus. New York: Columbia University Press, 1966.
77. Rafal RD Visually guided behavior. In: I, Litvan, Y, Agid, editors. Progressive supranuclear palsy: Clinical and research approaches. New York: Oxford University Press, 1992; 204-222.
78. Rafal RD, Grimm RJ. Progressive supranuclear palsy: Functional analysis of the response to methysergide and antiparkinsonian agents. Neurology 1981; 31(12): 1507-18.
79. Rafal RD, Posner MI. Deficits in human visual spatial attention following thalamic lesions. Proc Natl Acad Sci U S A 1987; 84: 7349-7353.
80. Rascovsky K, Salmon DP, Ho GJ, Galasko D, Peavy GM, Hansen LA, Thal LJ. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology 2002; 58(12): 1801-8.
81. Rey GJ, Tomer R., Levin BE, Snachez-Ramos J, Bowen BB Psychiatric symptoms, atypical dementia and left visual field inattention in corticobasal ganglionic degeneration. Mov Disord 1995; 10: 106-110.
82. Riklan M. Levodopa and behavior. Neurology 1972; 22(5-2): 43-55.
83. Simard M, van Reekum R, Myran D. Visuospatial impairment in dementia with Lewy bodies and Alzheimer's disease: A process analysis approach. Int J Geriatr Psychiatry 2003; 18(5): 387-91.
84. Smyth GE, Stern K. Tumours of the thalamus - a clinico-pathological study. Brain 1938; 61: 339-374.
85. Soliveri P, Monza D, Paridi D, et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999; 53: 502-7.
86. Soliveri P, Monza D, Paridi D, et al. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2000; 69: 315-318.
87. Steele JC, Richardson JC, Olszewski J. Progressive Supranuclear Palsy. Arch Neurol 1964; 10: 333-758.
88. Victor M, Adams RD, Collins GH The wenicke-Korsakoff syndrome. Philadelphia: Davis, 1971.
89. Walker Z, Allen RL, Shergill S, Katona CL. Neuropsychological performance in Lewy Body dementia and Alzheimer's Disease. Br J Psychiatry 1997; 170: 156-158.
90. Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, Poewe W, Jellinger K, Ray Chaudhuri K, D'Olhaberriague L, Pearce RK Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64(2): 184-9.
91. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981; 10(2): 122-6.
92. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 1982; 215(4537): 1237-9.
93. Winkelman NW. Progressive pallidal degeneration a new clinicopathologic syndrome. Arch Neurol Psychiatry 1932; 27: 1-21.
94. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Hayashi T, Konishi J, Kimura J. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration.. Arch Neurol 1998; 55(5): 609-14.